Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Supernus Pharm (SUPN)

Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,934,610
  • Shares Outstanding, K 57,339
  • Annual Sales, $ 661,820 K
  • Annual Income, $ 73,870 K
  • EBIT $ 46 M
  • EBITDA $ 128 M
  • 60-Month Beta 0.71
  • Price/Sales 4.23
  • Price/Cash Flow 12.30
  • Price/Book 2.80

Options Overview Details

View History
  • Implied Volatility 58.83% (+1.91%)
  • Historical Volatility 24.51%
  • IV Percentile 96%
  • IV Rank 70.29%
  • IV High 73.67% on 02/18/25
  • IV Low 23.73% on 06/11/25
  • Expected Move (DTE 8) 3.74 (7.28%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 26
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 2,596
  • Open Int (30-Day) 2,714
  • Expected Range 47.60 to 55.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.14
  • Number of Estimates 2
  • High Estimate 0.16
  • Low Estimate 0.12
  • Prior Year 0.61
  • Growth Rate Est. (year over year) -77.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.29 +8.56%
on 02/03/26
52.50 -2.21%
on 01/12/26
+0.23 (+0.45%)
since 01/09/26
3-Month
44.05 +16.55%
on 11/18/25
52.50 -2.21%
on 01/12/26
+5.23 (+11.34%)
since 11/11/25
52-Week
29.16 +76.06%
on 05/07/25
57.65 -10.95%
on 10/30/25
+12.69 (+32.83%)
since 02/11/25

Most Recent Stories

More News
1 Cash-Heavy Stock on Our Buy List and 2 We Brush Off

1 Cash-Heavy Stock on Our Buy List and 2 We Brush Off

NSSC : 43.00 (+0.87%)
SUPN : 51.34 (+0.31%)
CFR : 146.26 (unch)
1 Healthcare Stock to Consider Right Now and 2 We Brush Off

1 Healthcare Stock to Consider Right Now and 2 We Brush Off

OMCL : 37.82 (-3.03%)
SUPN : 51.34 (+0.31%)
VRTX : 461.24 (-0.48%)
2 Cash-Producing Stocks to Consider Right Now and 1 Facing Headwinds

2 Cash-Producing Stocks to Consider Right Now and 1 Facing Headwinds

NTRA : 212.46 (+0.38%)
SYK : 363.70 (+0.73%)
SUPN : 51.34 (+0.31%)
3 Unprofitable Stocks We Steer Clear Of

3 Unprofitable Stocks We Steer Clear Of

BYND : 0.7089 (-5.48%)
SUPN : 51.34 (+0.31%)
VRNS : 26.29 (+0.11%)
3 Low-Volatility Stocks We’re Skeptical Of

3 Low-Volatility Stocks We’re Skeptical Of

LKQ : 34.80 (+0.58%)
WABC : 51.85 (-0.13%)
SUPN : 51.34 (+0.31%)
3 of Wall Street’s Favorite Stocks That Concern Us

3 of Wall Street’s Favorite Stocks That Concern Us

PTLO : 5.81 (-2.52%)
TRNS : 78.09 (-2.06%)
SUPN : 51.34 (+0.31%)
1 Cash-Heavy Stock for Long-Term Investors and 2 We Turn Down

1 Cash-Heavy Stock for Long-Term Investors and 2 We Turn Down

OSCR : 13.60 (+5.59%)
SUPN : 51.34 (+0.31%)
PRVA : 21.60 (-1.01%)
3 Stocks Under $50 That Concern Us

3 Stocks Under $50 That Concern Us

SUPN : 51.34 (+0.31%)
PEBO : 33.33 (-0.89%)
PRDO : 30.47 (-2.56%)
3 Unprofitable Stocks We Find Risky

3 Unprofitable Stocks We Find Risky

AAP : 59.63 (+5.35%)
SUPN : 51.34 (+0.31%)
CNC : 40.43 (+2.07%)
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference

ROCKVILLE, Md., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central...

SUPN : 51.34 (+0.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit...

See More

Key Turning Points

3rd Resistance Point 53.66
2nd Resistance Point 52.63
1st Resistance Point 51.99
Last Price 51.34
1st Support Level 50.32
2nd Support Level 49.29
3rd Support Level 48.65

See More

52-Week High 57.65
Last Price 51.34
Fibonacci 61.8% 46.77
Fibonacci 50% 43.40
Fibonacci 38.2% 40.04
52-Week Low 29.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar